Hyperosmolar agents and clearance of mucus in the diseased airway.
about
Cystic fibrosisIonic imbalance, in addition to molecular crowding, abates cytoskeletal dynamics and vesicle motility during hypertonic stress.Airway Epithelial Cell Cilia and Obstructive Lung DiseaseUnfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.Hydration and disease.Hypertonic saline treatment of cystic fibrosis.Hypertonic stress promotes autophagy and microtubule-dependent autophagosomal clustersInhaled mannitol in cystic fibrosis.Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic FibrosisDesign, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.The Likelihood of Preventing Respiratory Exacerbations in Children and Adolescents with either Chronic Suppurative Lung Disease or Bronchiectasis.Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.Emerging drugs for bronchiectasis.Effect of inhaled dry powder mannitol on mucus and its clearance.The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.In vivo X-ray imaging reveals improved airway surface hydration after a therapy designed for cystic fibrosis.Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.Organic and inorganic fractions of diesel exhaust particles produce changes in mucin profile of mouse trachea explants.Emerging drug treatments for cystic fibrosis
P2860
Q24680357-7EB1761E-0B8B-4C68-B057-1D1E03F9519DQ27325433-E39CF281-2C17-401A-B993-1A8F25BB35CCQ28074301-E2C9D65F-B011-44A2-9306-99B7D8F55CA8Q33298018-D4805C9B-3E28-42D3-96D9-4EE2D9B55556Q34699361-37EFBADA-F411-467A-8210-2AF34607AF48Q36747002-1EA3F1C8-98AF-4FD5-970A-7BCE219972AAQ36769706-5B4C7EAC-16EF-4290-9042-30A67CC23DF9Q36861632-1EB6BE06-D2F1-4D24-A69B-6E76559285E2Q37241563-842A3FBF-7552-48A5-A63D-A60497D7FD25Q37667617-EB9FBB00-249A-43A4-89EE-BBEF455C9079Q37718996-BEB7E0BA-659F-43AF-80DB-33FA32D5CA11Q38007997-218D21E9-D7D6-4EF8-8A86-5BA2598FB95BQ38027233-670B7071-A67E-4806-8529-A940B1CC7267Q38077798-7AD50E13-926F-48BD-B02F-2A5FC2E0FBF0Q40093203-92F2C335-C0CA-442C-A05E-A91102AB8D28Q42345917-CE1D416B-8B79-4E4E-9257-08F54C0E3AE4Q46274587-EFEF36A3-7473-4136-B89E-54DE51FA6CFDQ47730320-BE928045-676A-4BB8-AEBD-8A8F2164247DQ51659219-9083B43D-4F47-426E-9CD3-0015CAF51C68Q57952080-B5460222-4339-42DF-9A06-3CF0420E9F8D
P2860
Hyperosmolar agents and clearance of mucus in the diseased airway.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Hyperosmolar agents and clearance of mucus in the diseased airway.
@ast
Hyperosmolar agents and clearance of mucus in the diseased airway.
@en
type
label
Hyperosmolar agents and clearance of mucus in the diseased airway.
@ast
Hyperosmolar agents and clearance of mucus in the diseased airway.
@en
prefLabel
Hyperosmolar agents and clearance of mucus in the diseased airway.
@ast
Hyperosmolar agents and clearance of mucus in the diseased airway.
@en
P356
P1476
Hyperosmolar agents and clearance of mucus in the diseased airway.
@en
P2093
Evangelia Daviskas
P304
P356
10.1089/JAM.2006.19.100
P577
2006-01-01T00:00:00Z